SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-18-000142
Filing Date
2018-01-12
Accepted
2018-01-12 15:36:19
Documents
73
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 347483
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7347
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 7578
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3099
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3305
  Complete submission text file 0001062993-18-000142.txt   3516660

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lxrp-20171130.xml EX-101.INS 360770
7 XBRL SCHEMA FILE lxrp-20171130.xsd EX-101.SCH 99138
8 XBRL CALCULATION FILE lxrp-20171130_cal.xml EX-101.CAL 48346
9 XBRL DEFINITION FILE lxrp-20171130_def.xml EX-101.DEF 366253
10 XBRL LABEL FILE lxrp-20171130_lab.xml EX-101.LAB 614866
11 XBRL PRESENTATION FILE lxrp-20171130_pre.xml EX-101.PRE 414138
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52138 | Film No.: 18525884
SIC: 1000 Metal Mining